Vertex executives warned that Casgevy, its curative treatment for sickle cell disease, would be slow to reach patients. But ...
In the era of personalized oncology, implementation of reliable biomarkers with prognostic and predictive value is necessary, the latter being most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results